by Jackie (née Heneghan) Peck | May 23, 2017 | Blog, Brexit, Good Distribution Practice - GDP, WDA(H)
The UK triggered Article 50 of the Treaty on European Union on 29th of March 2017 and as a result all primary and secondary law ceases to apply to the UK from 30th of March 2019. Companies who hold centrally authorised “MA s” must proactively review their MA terms,...
by Jackie (née Heneghan) Peck | May 12, 2017 | Blog, Consultancy, External Audit, Good Distribution Practice - GDP, Licence Acquisition, MHRA, Regulation, RP, WDA(H), WDA(H)
Do what I say not what I do, how many of us heard this from our parents & teachers or at least thought that it was one of their mottos? Unfortunately this seems to be a common theme in interactions with all sorts of official bodies as well, now I am not daft...
by Jackie (née Heneghan) Peck | Apr 3, 2017 | Blog, Falsified Medicines, MHRA, Regulation, WDA(H)
The Safety Features Team have set up a mail box for queries you might have regarding the new FMD requiring the registering of products onto the new EMVO portal: [email protected]
by Jackie (née Heneghan) Peck | Feb 21, 2017 | Blog, Good Distribution Practice - GDP, MHRA, Quality Systems, Regulation, RP, SOPs, WDA(H)
Risk Assessments and Self-audits should cover the whole of your GDP activities during the year. It is best to plan and ensure that you also conduct at least a couple of process audits. Prior to conducting risk assessments, you should look for evidence and discuss with...
by Jackie (née Heneghan) Peck | Feb 20, 2017 | Blog, Export Training, MHRA, Regulation, RP, Training, Transportation, WDA(H)
The MHRA inspectors have said that they are now focusing on the transport of medicines, and that more “Majors and Criticals” will be issued if UK wholesalers are not compliant. RPs have had over 3 years now to affect the changed required by current GDP guidelines. RPs...
by Jackie (née Heneghan) Peck | Feb 13, 2017 | Blog, Bona Fides, Consultancy, CQC, Distance Selling Pharmacy, EudraGMDP, Falsified Medicines, Good Distribution Practice - GDP, GPhC, MHRA, Pharmacist, Quality Systems, Regulation, setting up a pharmacy business, SOPs, WDA(H), WDA(H)
What is the risk of not meeting you suppliers and customers face to face? Call me old fashioned but I like to know who I am dealing with. I like to see the white of their eye, their premises, their procedures. With Valentine’s Day, fast approaching sweethearts are...
